To assess the regulation of stem factor factor (SCF) gene expression during spermatogenesis, we tested the effects of hormones (FSH, testosterone, and some growth factors [transforming growth factor-␤ (TGF␤), TGF␣, tumor necrosis factor-␣, and activin] on SCF gene expression by using a transillumination-assisted microdisection technique, a seminiferous tubule culture system, and Northern hybridization. Our results showed that FSH (10 ng/ml) increased steady state levels of SCF messenger RNA (mRNA) in a stage-specific and time-dependent manner. 8-Bromo-cAMP could increase the SCF mRNA level in a similar way as FSH, whereas phorbol 12-myristate 13-acetate had no effect. Actinomycin D could abolish the stimulatory effect of FSH, whereas cyclohexamide could not. The half-life of SCF mRNA was apparently prolonged after FSH stimulation (FSH-treated tubules, 15.6 Ϯ 1.2 h; controls, 8.6 Ϯ 2.7 h). Nuclear run-on assay revealed 5-and 10-fold increases in the transcription rate after FSH stimulation for 8 and 30 h, respectively. Neither testosterone nor estradiol had significant effects on SCF gene expression in our tissue culture system. Activin, TGF␤, TGF␣, and tumor necrosis factor-␣ had no effect on SCF gene expression in vitro.
S
TEM CELL factor (SCF), the ligand for the c-Kit receptor, is a growth factor with a broad range of biological activities. SCF binds selectively to cells that express c-kit, and its interaction with c-kit is crucial in the development of hematological, gonadal and pigment stem cells (1) (2) (3) . SCF is an integral membrane glycoprotein encoded at the Steel locus (4) . Two forms of messenger RNA (mRNA) due to alternative splicing of exon 6 result in two forms of protein, the membrane-associated form and the soluble form (5) . During testicular development, the membrane-associated form becomes predominant from day 5 of postnatal life onward, whereas the soluble form is relatively constant during the development (6, 7) . SCF has been localized to Sertoli cells in the rat testis, and the membrane-associated form could interact with the c-Kit receptor on type A spermatogonia, and the soluble form could potentially reach to the distal targets such as c-Kit on Leydig cells in the interstitium (8) . The sterility of the mice with deletions or mutations at the steel locus implicates the importance of SCF during testicular development and spermatogenesis (9) . Previous in vitro studies also showed that SCF could induce an increase in thymidine incorporation in isolated rat spermatogonia (10) and prevent spermatogonia from apoptosis (11) .
Previously, it was shown that FSH was able to stimulate SCF expression in a primary Sertoli cell culture system, and this effect was more prominent in cells isolated from the 13-day-old than in cells from 18-day-old rat testis (10) . However, other experimental models failed to show links between FSH and SCF (12) . To assess the potential regulation of SCF gene expression during spermatogenesis, we tested the effects of hormones (FSH, testosterone, and 17␤-estradiol) and some growth factors [transforming growth factor-␤ (TGF␤), TGF␣, tumor necrosis factor-␣ (TNF␣), and activin] on SCF gene expression by using a transillumination-assisted microdisection technique (13) , a seminiferous tubule culture system (14) and Northern hybridization.
Materials and Methods

Hormones and growth factors
Recombinant human FSH (Org 32489; 10,000 IU/mg) was provided by Organon (Oss, The Netherlands). Recombinant human TGF␤ and TNF␣ were purchased from Genzyme (Cambridge, MA). Recombinant human TGF␣ was from Immugenex (Immugenex, Los Angeles, CA). Recombinant human activin was obtained from the National Hormone and Pituitary Distribution Program, NIDDK, NIH. Testosterone, 17␤-estradiol, actinomycin D, and cyclohexamide were purchased from Sigma Chemical Co. (St. Louis, MO).
Experimental animals
Sprague-Dawley rats at 2-3 months of age were housed in a constant temperature (20 C) and light-dark cycle (lights on, 0600 -2000 h) with free access to food and water.
Tissue culture and stimulation
Twenty pieces of 5-mm long seminiferous tubule segments were incubated in 1 ml of the above-mentioned culture medium in the presence and absence of FSH (10 ng/ml), testosterone (10 6 m), 17␤-estradiol (10 Ϫ8 m), activin (10 and 100 ng/ml), TGF␣ (10 ng/ml), TGF␤ (1 ng/ml), and TNF␣ (12.5 ng/ml) for 8 and 30 h. Seminiferous tubule segments from stages II-VI were cultured and stimulated with or without 8-bromo-cAMP (8Br-cAMP; 1 mm), the phorbol ester (100 nm) phorbol 12-myristate 13-acetate (TPA), actinomycin D (0.5 g/ml), and cyclohexamide (10 g/ml) for 8 and 30 h.
Measurement of the half-life of SCF mRNA
Seminiferous tubule segments from stages II-VI were preincubated in the medium with or without FSH (10 ng/ml) for 8 h, and then actinomycin D (0.5 g/ml) was added. At 0, 6, 12, and 24 h after the addition of actinomycin D, the seminiferous tubule segments were harvested, and SCF mRNA levels were detected by Northern blot hybridization.
Riboprobe preparation and Northern blot hybridization
The pGEM 3Z plasmid containing a 560-bp long insert from the rat SCF complementary DNA (cDNA; provided by Amgen, Inc., Thousand Oaks, CA) was linearized with HindIII as the template for preparation of the antisense riboprobe. The riboprobe was synthesized using a Riboprobe system II kit (Promega Corp., Madison, WI) and [ 32 P]UTP (Amersham, Aylesbury, UK). Total RNA was isolated from seminiferous tubules by a single step method (15) . Ten micrograms of total RNA were size-fractionated in 1% denaturing agarose gel and transferred onto Hybond-N ϩ nylon membrane (Amersham). The prehybridization and hybridization were performed as described previously (16) . After hybridization with the SCF probe, the blots were stripped by pouring the boiling 0.1% SDS onto the membrane and incubated until the solution reached room temperature. The stripped membrane was subsequently used for hybridization with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA probe labeled with [ 32 P]deoxy-CTP (Amersham) by random priming method (Prime-a-Gene Kit, Promega Corp.) at 45 C overnight. Washing and autoradiography were performed similarly to SCF probing.
Preparation of nuclei and nonradioactive nuclear run-on assay
Seminiferous tubule segments of pooled stages II-VI that were cultured in the medium with or without FSH for 8 and 30 h were isolated by solubilizing the tubules in an isotonic solution containing 10 mm Tris-HCl (pH 8.0), 1 mm EDTA, 3 mm CaCl 2 , 1 mm dithiothreitol (DTT), 2 mm MgCl 2 , 0.32 m sucrose, and 0.1% (vol/vol) Nonidet P-40 and homogenizing sufficiently with a disposable syringe with a 22-gauge needle. The lysate containing the crude nuclei was mixed with 1 vol sucrose cushion solution containing 10 mm Tris-HCl (pH 8.0), 1 mm EDTA, 3 mm CaCl 2 , 1 mm DTT, 2 mm MgCl 2 , and 2 m sucrose, and then layered on 2 vol of the sucrose cushion. The gradient was centrifuged at 30,000 ϫ g (20,000 rpm in TLS-55 rotor, TL-100 Ultracentrifuge, Beckman Coulter, Inc., Palo Alto, CA) for 45 min at 4 C, and the nuclear pellet was suspended in a glycerol storage buffer containing 50 mm Tris-HCl (pH 8.0), 5 mm MgCl 2 , 0.1 mm EDTA, and 40% (vol/vol) glycerol and frozen in liquid nitrogen. Nuclear run-on experiments were performed according to the method described previously (17) with modification. Briefly, frozen nuclei (100 l containing 1-3 ϫ 10 7 nuclei) were thawed and mixed with 1 vol transcription 2 ϫ buffer containing 10 mm Tris-HCl (pH 8.0); 5 mm MgCl 2 ; 0.3 m KCl; 1 mm DTT; 0.2 mm EDTA; 5 mm ATP, GTP, and CTP; and 4 l digoxigenin-UTP (10 nmol/l; Boehringer Mannheim, Mannheim, Germany), and the mixture was incubated at 32 C for 2 h. Twenty microliters of RQ1 ribonuclease-free deoxyribonuclease I (1 U/l; Promega Corp.) and 2 l 1 m CaCl 2 were added to the reaction, and the incubation was continued for 15 min at 37 C. Three volumes of denaturing solution [4 m guanidinium thiocyanate, 25 mm sodium citrate (pH 7.0), 0.5% sodium lauroylsarcosine, and 0.1 m ␤-mercaptoethanol] was added to the reaction, and total RNA was isolated by the single step method (15) . The yield of the synthesized RNA was measured by both spectrophotometer and the dot blot-based detection assay according to the manufacturer's instruction (DIG System User's Guide for Filter Hybridization, Boehringer Mannheim). Ten micrograms of the labeled RNA were used for hybridization. The pGEM 3Z plasmid containing the SCF insert and the pGEM 3Z without any insert were heat denatured and blotted onto Hybond-N ϩ nylon membrane (Amersham). The blots were hybridized in 15 ml hybridization solution containing 50% formamide, 3 ϫ SSC (1 ϫ SSC ϭ 150 mm NaCl and 15 mm sodium citrate, pH 7.0), 5 ϫ Denhart's solution, 1% SDS, 0.1 g/liter heatdenatured calf thymus DNA, and 100 mg/liter yeast transfer RNA at 65 C overnight. After hybridization, the blots were washed twice in 2 ϫ SSC-0.1% SDS at 65 C for 15 min each and twice in 0.1 ϫ SSC-0.1% SDS at 65 C for 20 min each. The digoxigenin-chemiluminescent detection procedure was performed according to the manufacturer's protocol. The exposure time of x-ray films (Fuji Photo Film Co., Ltd., Tokyo, Japan) was between 1-4 h.
Densitometric analysis
The x-ray films of Northern blotting and run-on assay results were first scanned by a UMAX scanner (UMAX Technologies, Inc., Fremont, CA) and a Binuscan Photoperfect software package (Binuscan Inc., New York, NY). The images were saved as TIFF-type files (*.tif, Microsoft Corp. and Aldus Co., New York, NY) and then quantified by TINA 2.0 densitometric analytical system (Raytest Isotopenmesgerate GmbH, Straubenhardt, Germany) according to the manufacturer's instruction.
Replication of experiments and statistical analysis
All the experiments were repeated independently three times. In all Northern hybridization analyses, the densitometric values of the signals of SCF mRNA were first normalized to GAPDH signals and then the highest densitometric value was designated as 100%. Other values were expressed as the percentages of the highest one. The values from all the experiments were pooled for the calculation of the means, and their ses and for one-way ANOVA and Duncan's new multiple range test to determine the significant differences between different experimental groups by using StatView 4.51 statistic program (Abacus Concepts, Inc., Berkeley, CA). P Ͻ 0.05 was considered statistically significant. For half-life determination, a simple regression test was performed by using the same statistic program as mentioned above.
Results
FSH up-regulation of SCF gene expression
The steady state levels of SCF mRNA were dramatically elevated by FSH in four pooled stages after 30-h stimulation. The induction occurred in a time-dependent and stagespecific manner (Fig. 1) . SCF mRNA level in stages II-VI increased about 1.5-fold (P Ͻ 0.05) and 5-fold (P Ͻ 0.01) after 8-and 30-h stimulation, respectively. The extents to which the SCF mRNA level increased were different among the four pooled stages of the rat seminiferous tubules (P Ͻ 0.05). In stages II-VI, SCF mRNA level had an approximately 5-fold (P Ͻ 0.01) increase after 30-h FSH stimulation, whereas in stages VII-VIII, only about a 1.5-fold (P Ͻ 0.05) increase was observed after the same period of stimulation. At stages IX-XII and stages XIII-I, SCF mRNA level increased 3.0-(P Ͻ 0.01) and 3.5-fold (P Ͻ 0.01), respectively.
Lack of effects of testosterone and 17␤-estradiol on SCF gene expression
We also tested the effects of testosterone and 17␤-estradiol on SCF gene expression by using the same time points as those in FSH stimulation experiments. However, neither of these had significant effects on the SCF gene expression in our tissue culture system (data not shown).
Lack of effect of TGF␤, TGF␣, TNF␣, and activin on SCF gene expression
TGF␤, TGF␣, TNF␣, and activin are growth factors that have been found to be expressed in the seminiferous epithelium and supposed to play important roles during spermatogenesis (18 -20) . However, the detailed mechanisms by which their function is coordinated in space and time are largely unknown. To test whether they are involved in the regulation of SCF gene expression, we tested the effects of these factors as well. However, no effects were observed at the tested dose levels (data not shown).
Effects of 8Br-cAMP and TPA on SCF gene expression
Because of the highest stimulation of SCF mRNA level at stages II-VI, we selected the pooled seminiferous tubule segments at these stages for further studies on the mechanisms by which FSH up-regulates SCF gene expression. FSH binds to specific FSH receptors on Sertoli cell membranes and causes an increase in intracellular cAMP level or activation of protein kinase C to induce gene expression in the Sertoli cells (21) . The induction of the gene expression by FSH can be reproduced by cAMP analogs, such as 8Br-cAMP, when it is mediated through cAMP/protein kinase A pathway or by the phorbol ester, TPA, a protein kinase C activator, when it is mediated via the protein kinase C (PKC) pathway. To test whether FSH stimulation of SCF gene expression is mediated by cAMP/protein kinase A (PKA) pathway or PKC pathway, seminiferous tubule segments from stages II-VI were incubated in the presence or the absence of 8Br-cAMP or TPA for 8 and 30 h, respectively. SCF mRNA level was increased by 8Br-cAMP in a similar manner to FSH, whereas TPA had no effects (Fig. 2) .
Confirmation of FSH up-regulation of SCF at transcriptional level
To test whether FSH stimulation of SCF gene expression occurs at the transcriptional level, seminiferous tubule segments of stages II-VI were stimulated with FSH in the absence and presence of actinomycin D. As shown in Fig. 2 , FSH stimulation was abolished after 8-and 30-h treatments with actinomycin D. The steady state levels of SCF mRNA decreased dramatically after RNA synthesis was blocked by actinomycin D for 30 h.
Independence of FSH up-regulation of de novo protein synthesis
To assess whether the up-regulation of SCF by FSH involves de novo protein synthesis, cyclohexamide, a protein synthesis inhibitor (22) , was used to treat the samples to- The rat seminiferous tubule segments from four pooled stages (II-VI, VII-VIII, IX-XII, and XIII-I) were incubated in the medium (see Materials and Methods) with or without FSH (10 ng/ml) at 34 C for 8 and 30 h. After incubation, SCF mRNA levels were analyzed by Northern hybridization. Subsequently, the blots were stripped and reprobed by GAPDH cDNA probe labeled with [␣- 32 P]deoxy-CTP. SCF mRNA levels were normalized to GAPDH mRNA levels for correcting loading variation. The highest mRNA levels, which are always found at stages II-VI after 30-h FSH stimulation, are designated 100%, and other values are expressed as percentages of the highest value. Each bar represents the mean Ϯ SEM of three independent experiments. ADU, Arbitrary densitometric units. *, P Ͻ 0.05; **, P Ͻ 0.01 (compared with controls).
FIG. 2. Effects of 8Br-cAMP, TPA, actinomycin D (AD)
, and cyclohexamide (CHX) on SCF gene expression. The seminiferous tubule segments from stages II-VI were incubated in the medium containing FSH (10 ng/ml), 8Br-cAMP (1 mM), TPA (100 mM), FSH (10 ng/ml) plus AD (0.5 g/ml), FSH (10 ng/ml) plus CHX (10 g/ml), or vehicle (controls) for 8 and 30 h at 34 C. After incubation, SCF mRNA level was analyzed by Northern hybridization. Subsequently, the blots were stripped and reprobed by GAPDH cDNA probe labeled with [␣-32 P]deoxy-CTP. SCF mRNA levels were normalized to GAPDH mRNA levels for correcting loading variation. The highest mRNA level, which were found in stages II-VI after 30-h FSH stimulation, was designated 100%, and other values are expressed as the percentages of the highest one. Each bar represents the mean Ϯ SEM of three independent experiments. ADU, Arbitrary densitometric units. Values with different letters are significantly different (P Ͻ 0.05).
gether with FSH. As shown in Fig. 2 , cyclohexamide did not affect the FSH stimulation.
Prolongation of the half-life of SCF mRNA after FSH stimulation
The elevated SCF mRNA level can be contributed either by an increase in transcription or a decrease in mRNA degradation. To study whether the stability of SCF mRNA was increased after FSH stimulation, the half-life of SCF mRNA with and without FSH stimulation was determined by the actinomycin D-blocking method (23) . It has been reported that actinomycin D may prolong the half-life of some unstable mRNAs and long lasting blocking of transcription can also kill the cells (24) . In our study, we tried different concentration of actinomycin D (0.1, 0.5, 1, 5, and 10 g/ml) and different incubation time points (8, 24 , and 30 h) by using four pools of seminiferous tubule segments because the stagespecific expression pattern of SCF mRNA served as a good marker of the viability of the cells. We found that the concentration used in the main experiments (0.5 g/ml) was the optimal one at which SCF gene transcription was completely blocked, and the characteristic of the stage-specific expression pattern of SCF mRNA was still observed after 30 h of incubation (data not shown). As both control and FSH-stimulated samples were treated with actinomycin D, we could compare transcript half-lives of both groups. As shown in Fig. 3 , the decrease in SCF mRNA was slower when the seminiferous tubules were pretreated with FSH for 8 h compared with the control. The SCF mRNA half-lives, as calculated by regression analysis, were 15.6 Ϯ 1.2 h for the FSHtreated samples and 8.6 Ϯ 2.7 h for the control (n ϭ 3; P Ͻ 0.05).
Effect of FSH on transcription rate of SCF gene
To further study changes in transcription rate after FSH stimulation, a nuclear run-on assay was performed. As shown in Fig. 4 , the transcription rate of SCF gene was increased significantly in a time-dependent manner (n ϭ 3; P Ͻ 0.01). Five-and 10-fold increases in transcription rates were observed after 8-and 30-h FSH stimulation, respectively. PGEM 3Z plasmid as a negative control gave very weak signals and was used for correction of the nonspecific binding.
Discussion
In the present study we applied the transilluminationassisted microdisection of seminiferous tubules at defined stages of the epithelial cycle and in vitro tissue culture system to study the effects of FSH, testosterone, estradiol, TGF␣, TGF␤, TNF␣, and activin on the SCF gene expression. In this tissue culture system, germ cells and Sertoli cell are cocultured, and the communication between germ cells and Sertoli cells was maintained intact (14) . Our previous study showed that SCF was expressed at the highest level in stages II-VI, at the lowest level in stages VII-VIII, and at an intermediate level in stages IX-I (Hakovirta H., et al., parallel manuscript). In the present study, we used the stage-specific expression pattern of SCF as an internal control to monitor the culture condition to assure the validity of our data.
In the hormonal stimulation experiments, we found a significant induction of SCF mRNA level after 8 and 30 h of FSH stimulation. It is of interest to note that FSH differentially stimulated SCF gene expression at different stages of the seminiferous epithelial cycle. The maximal increase in SCF mRNA level was found at stages II-VI, implicating that more SCF might be needed in these stages than in other stages. The minimum increase was observed at stages VII-VIII. It has previously been documented that many genes expressed in Sertoli cells, show stage-specific expression pattern, e.g. activin (25, 26) , inhibin-␣ (27) , and proenkephalin (28). Our results, for the first time, show that SCF is not only expressed differentially in Sertoli cells, but also is responsive to FSH differentially at different stages of the seminiferous epithelial cycle. We suggest that the stage-specific steady state level of SCF mRNA might result from the stage-specific responsiveness of SCF gene in Sertoli cells to FSH at different stages of the seminiferous epithelial cycle.
To understand the regulatory mechanism in detail, we further tested the effects of 8Br-cAMP, a cAMP analog and PKA stimulator, and TPA, a PKC activator, on the SCF gene expression. The similar effect of 8Br-cAMP as FSH and the lack of an effect of TPA on SCF mRNA level indicate that the up-regulation of SCF gene expression is mediated through the cAMP/PKA pathway and not through the PKC pathway. The elevation of the SCF mRNA level resulted from the accumulation of SCF mRNA, which can be due to many transcriptional and posttranscriptional regulatory mechanisms. The fact that actinomycin D abolished the stimulatory effect of FSH on SCF gene expression suggests that the upregulation at least partially happened at transcriptional level. We then further measured the stability of SCF mRNA before and after FSH stimulation by using actinomycin D blocking method. The prolongation of the half-life of SCF mRNA after FSH stimulation indicates that the degradation rate of SCF mRNA was decreased after FSH stimulation. Cyclohexamide, a potent protein synthesis inhibitor, did not affect FSH stimulation. This result indicates that the FSH up-regulation of SCF mRNA level is independent of de novo protein synthesis. Transcription run-on assays make it possible to further analyze the changes in transcription rate before and after FSH stimulation. Although the nuclei isolated from the cultured seminiferous tubule segments are mixtures of the nuclei from Sertoli cells and germ cells, it is still possible to perform in vitro transcription run-on assays because SCF had been shown to be expressed only in Sertoli cells (7) . Nuclei from at least 15 cm of seminiferous tubules were needed for a successful reaction in our study. Our run-on results revealed a 5-fold increase and a 10-fold increase after 8-and 30-h FSH stimulation, respectively. However, in the Northern analyses, after 8-and 30-h FSH stimulation, only 1.5-and 5-fold increase in steady state SCF mRNA level were observed. The discrepancy suggests that there are some factors that can repress the SCF steady state mRNA level at the posttranscriptional level during the FSH stimulation.
No consistent effects on SCF mRNA expression in the seminiferous epithelium were found after testosterone and estradiol stimulation. It is known that testosterone is needed in Sertoli cells for the production of cAMP response element (CRE)-binding protein (CREB), which acts in cAMP stimulation of gene expression (29, 30) . A recent study (31) on the promoter of the human SCF gene showed that testosterone had no effect on human SCF promoter activity in the Sertoli cell line SF7, either by interaction with AR protein directly with the GRE sequence or by modulating expression of factors such as CREB, which might regulate the SCF promoter through CRE sequences. Our findings that testosterone had no effect on SCF gene expression further support the suggestion that the induction of SCF promoter activity by cAMP is not mediated by CRE sequences. No effect of estradiol was found in our study, although there is an activating protein-1 site on the SCF promoter according to the previous studies (31, 32) . As mentioned earlier, TPA, which has been found to increase the synthesis of c-fos and AP-1 by a PKC-dependent pathway and inhibit gene transcription in the rat GnRH promoter (33) (34) (35) , had no effect on SCF gene expression. This might suggest that estrogens are not the inhibitory regulators of SCF gene expression. No significant effects were found in growth factor stimulation experiments. It may be either the real situation in vitro or artificial due to the inappropriate time points or dosages we used. Thus, these negative findings may only represent the in vitro situation, and the possibility that the growth factors might have some effects on SCF gene expression in vivo cannot be ruled out.
In summary, SCF gene expression in the rat seminiferous epithelium was up-regulated by FSH in a stage-specific and time-dependent manner. The up-regulation of FSH was mediated through the cAMP/PKA pathway, not through the PKC pathway. The up-regulation of the SCF mRNA level was due to the increase in the transcription rate and the prolongation of the mRNA half-life, but it was independent of de novo protein synthesis. Testosterone, estradiol, TGF␣, TGF␤, TNF␣, and activin had no effect on SCF gene expression in rat seminiferous tubules in vitro.
